Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution.

Area of Science:

• Drug discovery and development
• Chemical biology
• Pharmacology

Background:

• Renewed interest in phenotypic screening for novel small-molecule drug candidates.
• Challenge in identifying molecular targets of small molecules identified through phenotypic screening.
• Target identification is critical for understanding drug mechanisms, rational design, toxicology, and patient stratification.

Purpose of the Study:

• To review successful examples, limitations, and advances in drug target deconvolution using small-molecule affinity chromatography coupled with mass spectrometry (SMC-MS).
• To provide a comparative analysis of SMC-MS methods against other target deconvolution techniques.

Main Methods:

• Small-molecule affinity chromatography coupled with mass spectrometry (SMC-MS).
• Review of existing literature and case studies on SMC-MS applications.
• Comparative analysis with other target deconvolution strategies.

Main Results:

• SMC-MS is a popular and effective technique for identifying drug targets.
• Mass spectrometry-based methods deliver rapid, dependable, and information-rich data on targets.
• These methods enable system-wide understanding of drug-target interactions in complex biological systems.

Conclusions:

• Small-molecule affinity chromatography coupled with mass spectrometry is increasingly favored for target identification.
• Mass spectrometry-based approaches offer efficient and comprehensive insights into drug-target interactions.
• These techniques facilitate a holistic understanding of drug action within biological systems.